PolarityTE Inc.

PolarityTE — IPO Roadshow (April 2018)

34 slides from PolarityTE's IPO roadshow presentation, Apr 11, 2018

  1. Slide 1: PolarityTE - Where Self Regenerates Self

    EE — | NASDAGGOO ' woweWhere Sel Regeneratesiseljaq

  2. Slide 2: Forward Looking Statements

    FORWARD LOOKING STATEMENTS. This presentation contains forward-looking statements and projections. The company makes no express or implied representation or warrant as to the completeness of this information or, in the case of projections, as to their attainability or the accuracy and completeness o

  3. Slide 3: Free Writing Prospectus Statement

    FREE WRITING PROSPECTUS STATEMENT PolarityTE has filed a registration statement (including a base prospectus) with the SEC and will file a prospectus supplement in connection with any offering thereunder. Before you invest in any such offering, you should read the base prospectus in that registratio

  4. Slide 4: PolarityTE

    PolarityTE” A commercial-stage regenerative biomaterials and biotechnology company focused on transforming the lives of patients by delivering a range of functional tissues using our novel platform technology. oe

  5. Slide 5: Name one company or product that truly regenerates anything?

    im ss — a : - ie E ; Ask yourself—Name one company or product that xo @ truly regenerates ANYTHING? ‘ Ss ———

  6. Slide 6: The Problem with Regenerative Medicine is Tissue Engineering

    The Problem with Regenerative Medicine—is Tissue Engineering ee ee The Tissue Engineering Triad _ ae Tissue Engineered Skin Substitutes often seen as foreign by the body Tissue engineering triads, single cell suspension, growth factors, monolayer cultures and synthetic scaffolds struggle to regenera

  7. Slide 7: Question: What Has Been Missing?

    Question: What Has Been Missing? poelarsiety: the asymmetric organization of cellular elements, which allows development of specialized tissue and downstream function. (BD Polatyre

  8. Slide 8: Our Solution to Complex Tissue Regeneration is Polarity

    ur Solution to Complex Tissue Re ration is — Polarity The functional polarization of SkinTE is designed to regenerate full-thickness, hair-bearing skin with all of the appendages (hair follicle, glands, etc.) and layered interfaces (epidermis, dermis and hypodermis). We believe the subsequent full-t

  9. Slide 9: PolarityTE - We Design Platform Technologies

    PolarityTE™ - We Design Platform Technologies We believe precise design and development of our Core TE Tissue Systems, utilizing novel Minimally Polarized Functional Units (MPFUs), permits us to regenerate a full spectrum of functionally-polarized complex tissues AUTOLOGOUS- FROM THE PATIENT FOR THE

  10. Slide 10: Evolving Technology Platforms and Products

    PolarityTE™ - Welcome to the Sais 4 EVOLVING TECHNOLOGY PLATFORMS AND PRODUCTS = we We are a clinical stage, commercial biotechnology and regenerative materials company with new and expanding technology platforms which we believe can be utilized to create * functionally-polarized tissues for use in

  11. Slide 11: Our First Full-Thickness, Functionally-Polarized Tissue - SkinTE

    Our First Full-Thickness, Functionally-Polarized Tissue - SkinTE™ { From asmall piece of tissue to the regeneration, replacement and/or reconstruction of full-thickness, hair-bearing skin ] Product Designed for All SkinTE was specifically designed to reduce barriers to regenerative wound care treatm

  12. Slide 12: SkinTE: Designed to Address Current Critical Unmet Needs

    SkinTE™: Designed to Address Current Critical Unmet Needs Different Cells and Structures Exist at Different Layers within the Skin—Taking Only Some. of them Prevents the Regeneration of Full-Thickness Halr- Bearing Skin SKIN GRAFTS - LIMITED DONOR SKIN NATIVE DONOR SKIN IS LIMITED: Full-thickness au

  13. Slide 13: SkinTE Compared to Commercially Available Skin Substitutes

    SkinTE™ Compared to Commercially Available Skin Substitutes SkinTE Skin is much more than a single layer to provide a barrier - it is the largest organ in the human body and requires regeneration of all components for normal function. “[W]ithout the component of the recipients own distinct epitheliu

  14. Slide 14: The SkinTE Difference: Skin Regenerates Skin

    The SkinTE™ Difference Simply Put—Skin Regenerates Skin Direct Comparison of SkinTE Full-thickness Hair-bearing Skin Regeneration vs. Native Skin and Wound. Regenerative healing occurs through a process which not only regenerates the appropriate and necessary tissues, functions and interfaces but al

  15. Slide 15: SkinTE Mid-Stage Regenerative Wound

    SkinTE™ Mid-Stage Regenerative Wound Mid Stage SkinTE imegrative Convergence with Native Skin Mid-Stage Native Contracting Wound “Marginal Contraction and Migration — Epithelial Migration Columns Native Healed and Contracted Wound Pseudo-epitheium Covering the Underying Scar SkinTE™ Regenerative Hea

  16. Slide 16: Full-Thickness Skin Regeneration in Full-Thickness Wounds

    Full-Thickness Skin Regeneration in Full-Thickness Wounds PolarityTE™ Minimally Polarized Function Units Regenerate the Appendages of the Skin—Those Appendages then Regenerate the Full-Thickness Hair-Bearing Skin MPFU Regeneration of Appendages within the Skin Drives Directional Polarization of Cell

  17. Slide 17: Comparing the Clinical Standard of Care to SkinTE

    Comparing the Clinical Standard of Care to SkinTE™ Native Scar Healed Wound Native Skin Allograft Margin _ Native Skin { i ‘ , q Full-Thickness Allograft E ‘Autograft |\\ margin Native Skin } y \ Skin defects heal through a process of wound contraction and often scar formation. While skin grafts red

  18. Slide 18: Native Skin

    Native Skin eS NESS : 3 ‘Comparing SkinTE™ to Native Skin. Comparative of analysis of ancillary histology between SkinTE™ (left) and native skin (right). Ancillary stains include: Hematoxylin and Eosin, Trichrome and Periodic Acid-Schiff. The images and data presented here are from pre-clinical stud

  19. Slide 19: SkinTE - Early-Stage Healing in Patients

    SkinTE™ - Early-Stage Healing in Patients SkinTE™ was designed and developed to treat a full spectrum of defects and conditions of the skin in a manner which truly promotes and utilizes the concept of self regeneration early on in the healing process —Where Self Regenerates Self™ Conditions Treated

  20. Slide 20: SkinTE - Early-Stage Healing and Return of Pigment in Patients

    SkinTE™- Early-Stage Healing and Return of Pigment in Patients SkinTE™ was designed and developed to treat a full spectrum of defects and conditions of the skin In a manner which truly promotes and utilizes the concept of self regeneration early on In the healing process Where Self Regenerates Self™

  21. Slide 21: Current Technology Platform

    rent lechnology Platform Support Platform Dale

  22. Slide 22: Real-Time Assistant App

    PolarityTE™ Real-Time Assistant App An advisor will be a signed to assist you. This video can be viewed at: http://www. polarityte.com/rta_overview.mp4 ANew Wayto Communtcateand Use PolarityTE™ Products: The PolarityTE™ Real-Time Assistant App for 10S, Android and Computer Systems Allows Peer-to-Pee

  23. Slide 23: Regenerative Wound Care Market

    PolarityTE egenerative Wound Care Market | CURRENT MARKETS REMAIN UNDERPENETRATED Growth in Worldwide Prevalence of Wound Types, 2011-2020 Global markets for tissue engineering and regenerative medicine is expected to grow to > $100 sasgjoos J Conpliated sin eanee billion by 2022, with a five-year C

  24. Slide 24: SkinTE Commercialization & Growth

    SkinTE™ Commercialization & Growth Allin One Systems for Easy Use A STRATEGIC MARKET RELEASE a Further Intellectual Property Davelop ment Staged market release goals for 2018 focus on building a robust foundation of clinical evidence in multiple wound types and practice settings + Targeting recogniz

  25. Slide 25: The Core PolarityTE Product Pipeline

    The Core PolarityTE Product Pipeline Development Pipeline of PolarityTE Core “TE” Products. A pipeline chart depicting some of the public core “TE” tissue product candidates (defined complex tissue constructs for autologous-homologous use) and where such candidates are in the development process. No

  26. Slide 26: OsteoTE - Expected to Launch in Late 2018

    Os stgoTEM- Expected to Launch in Late 2018 B Ost This video can be viewed'at: http://www. polarityte.com/osteote_overview.mp4 Zz OsteoTE™ Is an autologous - fromthe patient, forthe patient - product Intended for bone repalt, reconstruction, replacement, supplementation and regeneration, Including I

  27. Slide 27: OsteoTE - Regeneration of Bone in Critical Defects

    OsteoTE™ — Regeneration of Bone in Critical Defects Pre-Defect Native (CT) Defect Native (CT) ogee ge oS) ct Treated (CT) - [ROI] 3 ss Comparative Imaging of CLKSAM Substrate in Critical zed Cranial Defect Mode ISystem. (2, Three dimen ional (3-0) micro cormputed tomography (micro-ci native cranial

  28. Slide 28: Polarized Interfaces Drive Vascularized Osteogenesis

    Polarized Interfaces Drive Vascularized Osteogenesis Comparing OsteoTE™ to Native Bone and Other Products ] olog Defect Control Native Bone i g 3 2 % & (2 pa vated 3 aS & en : . 3 OsteoTE DBM + BMP2 1 "i = & 8 Sy = sky! “se Pa x me : re . | n bar ie | a ‘ . j © otal 20.

  29. Slide 29: OsteoTE: Molecular Fingerprints Drive Functional Tissue

    E™: Molecular Fingerprints Drive Functional Tissue { Integrative Anglogenesis and Osteogenesis Correlate this with Functional Outcomes and Tissue Fingerprints Angiogenesis Profile OsteoTE +86 50 OsteoTE +06 Osteogenesis Profile OsteoTE \ native Bone i eo CNRS Load iN) ‘Auto Bone Flap DBM + BMP2 BD p

  30. Slide 30: Founders and Key Personnel

    DenverLough, MD, PhD eet Eve Ol & Cats Invantoonnoratrhahlnd patented PolarteyTE™plattrm dattertiver + Ioinad Platte trom the Deparment Joins Hepki Plastic end Reconsructva fresey + MDJPRD Program, Geargstown Univer in Blochaminry, Meade and Calltar clogy tte HSS soiaaioae ein eee oases hEcngetacore

  31. Slide 31: PolarityTE Management

    pa Management l ¢ Denver Lough, MD, PhD Chairman & Chief Executive Officer Edward (Ned) Swanson, MD 1 Chief Operating Officer, Director John Stetson Executive Vice President, Chief Ananda Officer, Director Sg Dee Steve Gorlin Director Regenerative Medicine and Biotech Pioneer Founder of Hycar Biomed

  32. Slide 32: The PolarityTEAM - Clinical Advisory Board

    The PolarityTEAM - Clinical Advisory Board wy

  33. Slide 33: PolarityTE Contacts

    S Folantyie ‘About = Pintform = Products Partners: Investor Relations, Functionally-Polarized _AtPolanyTE.ourfevoluionorypatorinis beingdevsloped to induce-lltnd site Polat, PolarityTE™ Corporate Website: www.PolarityTE.com Email: [email protected] © Corporate Inquiries: (800) 378-2694 Co

  34. Slide 34: Slide 34

PolarityTE — IPO Roadshow (April 2018) on 6ix